How by bowing down to short-sighted patient interest pressures the NHS may be harming others:
Funding the drug would mean 355 patients not receiving post-surgery treatment – 16 of whom would be cured, or around 200 patients not receiving palliative chemotherapy.
The researchers say there is little long-term data on the clinical benefits and potential dangers of taking Herceptin, whereas the established treatments have been shown to be clinically and cost effective.
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
